2seventy bio, Inc. (NASDAQ:TSVT) Q1 2023 Earnings Call Transcript May 3, 2023 4:30 PM ET
Company Participants
Jenn Snyder - SVP of Corporate Affairs
Nick Leschly - President, CEO & Director
Philip Gregory - Chief Scientific Officer
Steven Bernstein - Chief Medical Officer
William Baird - CFO
Conference Call Participants
Daina Graybosch - SVB Securities LLC
Operator
Good day, and thank you for standing by. Welcome to the 2seventy bio First Quarter 2023 Financial Results Conference Call. (Operator Instructions] Please be advised that this call is recorded.
I would now like to turn the call over to Jenn Snyder, Head of Corporate Affairs. You may begin.
Jenn Snyder
Thank you, Jayda. This afternoon, 2seventy bio issued a press release providing a business update in addition to first quarter 2023 financial results. The press release can be found in the Investors and Media section of the company's website at 270bio.com.
Speaking on the call today are Nick Leschly, Chief Kairos Officer; Chip Baird, Chief Financial Officer; and Philip Gregory, Chief Scientific Officer; Steve Bernstein, Chief Medical Officer, is also on the call for Q&A.
As a reminder, today's discussion will include forward-looking statements related to 2seventy bio's current plans and expectations, which are subject to certain risks and uncertainties. These forward-looking statements include statements regarding our strategic plans, time lines and expectations and statements regarding our financial condition, expectations and other future financial results, among others.
Actual results may differ materially due to various risks, uncertainties and other factors, including those described in the Risk Factors section of our most recent Forms 10-K and other SEC filings. These forward-looking statements represent our views as of this call and should not be relied upon as representing our views as of any subsequent date. You are cautioned not to place any undue reliance on these forward-looking statements. And except as required by law, we undertake no obligation to update or revise any forward-looking statements.
At this time, I would like to turn the call over to Nick Leschly. Nick?
Nick Leschly
Thank you, Jenn, and good afternoon, everyone. Thanks to everyone on the line for joining us as we discuss our first quarter 2023 results. We've had an incredibly strong start to the year and executed across all aspects of our business. Chip and Philip will take you through the details. We don't always host an earnings call, but given the amount of news we've had going on as of late, and the overall macro environment, we felt it was important to host a call to highlight what's new and our belief in the future of 2seventy.